Showing results (1-10 of 887) with videos related to

Sort By:
Pageof 89
Journal of the American Society of Nephrology : JASN|November 30, 2006
Lipid changes and statins in chronic renal insufficiencyEberhard Ritz, Christoph Wanner
Journal of the American Society of Nephrology : JASN|March 29, 2008
Lipid abnormalities and cardiovascular risk in renal diseaseEberhard Ritz, Christoph Wanner
Kidney International. Supplement|November 27, 2008
Reducing lipids for CV protection in CKD patients-current evidenceChristoph Wanner, Eberhard Ritz
Journal of the American Society of Nephrology : JASN|July 11, 2006
Cross-talk between the kidney and the cardiovascular systemKerstin Amann, Christoph Wanner, Eberhard Ritz
Circulation|December 2, 2009
Glycemic control and cardiovascular events in diabetic hemodialysis patientsChristiane Drechsler, Vera Krane, Eberhard Ritz, et al.
European Journal of Heart Failure|July 28, 2011
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patientsChristiane Drechsler, Andreas Meinitzer, Stefan Pilz, et al.
The New England Journal of Medicine|July 22, 2005
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysisChristoph Wanner, Vera Krane, Winfried März, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2009
The association between parathyroid hormone and mortality in dialysis patients is modified by wastingChristiane Drechsler, Vera Krane, Diana C Grootendorst, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysisVera Krane, Detlef H Krieter, Manfred Olschewski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2016
Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D StudyBarbara Kollerits, Christiane Drechsler, Vera Krane, et al.
Pageof 89